Related Experiment Video
Updated: May 27, 2025

09:47
Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches
Published on: December 15, 2023
940
Stacked CNN-based multichannel attention networks for Alzheimer disease detection
Najmul Hassan1, Abu Saleh Musa Miah1, Kota Suzuki1
1School of Computer Science and Engineering, The University of Aizu, Aizuwakamatsu, Fukushima, 965-0006, Japan.
Scientific Reports
|February 17, 2025
Summary
This study introduces a novel Stacked Convolutional Neural Network with Channel Attention Network (SCCAN) for Alzheimer's Disease (AD) classification using MRI scans. The SCCAN model achieves high accuracy, outperforming existing methods for early AD detection.
Area of Science:
- Neurology
- Artificial Intelligence
- Medical Imaging
Background:
- Alzheimer's Disease (AD) is a progressive neurological disorder characterized by cognitive decline.
- Current deep learning models for AD classification face challenges with accuracy and efficiency due to feature ineffectiveness.
- Automatic diagnosis systems for AD using medical images are crucial for early intervention.
Purpose of the Study:
- To propose a lightweight Stacked Convolutional Neural Network with a Channel Attention Network (SCCAN) for improved Alzheimer's Disease classification.
- To enhance feature extraction and selection for more effective AD recognition from MRI data.
- To develop a deep learning model suitable for training on smaller datasets and addressing class imbalance.
Main Methods:
- A novel SCCAN model integrating 5 CNN modules for hierarchical feature extraction.
- A channel attention module to select influential features based on channel dimension.
- Training and validation on diverse MRI datasets including ADNI1, Kaggle, and OASIS-1, addressing class imbalance.
Main Results:
- The SCCAN model demonstrated high classification accuracy: 99.58% (ADNI1), 99.22% (Kaggle), and 99.70% (OASIS-1).
- The model exhibits reduced parameters, making it efficient for training.
- Performance surpassed state-of-the-art models in Alzheimer's Disease classification.
Conclusions:
- The proposed SCCAN model offers a significant advancement in MRI-based Alzheimer's Disease classification.
- SCCAN provides an effective and accurate solution for automatic AD diagnosis.
- The lightweight design and high accuracy make SCCAN a promising tool for clinical application.
Related Concept Videos
Alzheimer's Disease: Overview
429
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
429
Alzheimer's Disease: Treatment
150
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
150
Dementia
91
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
The progression of dementia is generally gradual....
91

